Table 1

Cardiovascular profiles of AD military members diagnosed with AF categorised by treatment strategy

All
(n=386)
No therapy
(n=58)
Rate medical therapy
(n=155)
Rhythm medical therapy
(n=173)
P value
Age, years35.0±9.432.8±9.033.9±9.136.8±9.50.0130
Male, no. (%)360 (93%)53 (91%)142 (92%)165 (95%)0.3166
BMI, kg/m228.3±4.327.3±3.728.6±4.228.3±4.50.1202
Caucasian, no. (%)219 (57%)32 (55%)81 (52%)106 (61%)N/A
African American, no. (%)81 (21%)11 (19%)37 (24%)33 (19%)N/A
Asian/Pacific Islander, no. (%)9 (2%)3 (5%)3 (2%)3 (2%)N/A
Native American, no. (%)1 (0.3%)0 (0%)1 (0.6%)0 (0%)N/A
Hispanic, no. (%)3 (0.8%)1 (2%)2 (1%)0 (0%)N/A
Other/unknown race, no. (%)73 (19%)11 (19%)31 (20%)31 (18%)N/A
Hypertension, no. (%)91 (24%)9 (16%)37 (24%)45 (26%)0.2393
Obstructive sleep apnoea, no. (%)75 (19%)11 (19%)30 (19%)34 (20%)0.9934
Diabetes mellitus, no. (%)6 (2%)0 (0%)3 (2%)3 (2%)0.3699
Vascular disease, no. (%)4 (1%)0 (0%)2 (1%)2 (1%)0.5441
Prior TIA or CVA, no. (%)5 (1%)1 (2%)1 (0.6%)3 (2%)0.6293
Coronary artery disease, no. (%)8 (2%)1 (2%)1 (0.6%)6 (3%)0.1700
Heart failure, no. (%)12 (3%)0 (0%)6 (4%)6 (3%)0.1345
Glucose, mg/dL95.9±16.496.5±18.196.6±19.295.1±12.70.7113
Total cholesterol, mg/dL181.6±37.7184.1±37.4178.6±40.9183.5±35.00.5025
LDL, mg/dL112.4±46.8108.2±32.4112.9±62.4113.2±32.60.8022
HDL, mg/dL47.4±13.850.3±14.947.5±14.546.5±12.60.2262
Triglycerides, mg/dL121.8±88.81331.0±128.8118.1±81.3122.2±80.50.6647
CHA2DS2-VASc score0.39±0.650.31±0.540.39±0.600.42±0.730.4989
HAS-BLED score0.86±0.630.91±0.660.82±0.650.88±0.610.6043
AF classification
Paroxysmal, no. (%)361 (94%)57 (98%)150 (97%)154 (89%)0.0210
Persistent, no. (%)21 (5%)1 (2%)4 (3%)16 (9%)N/A
Permanent, no. (%)4 (1%)0 (0%)1 (1%)3 (2%)N/A
  • Values are number (%), mean (±1 SD).

  • AD, active duty; AF, atrial fibrillation; BMI, body mass index; CVA, cerebrovascular accident; HDL, high density lipoprotein; LDL, low density lipoprotein; N/A, not applicable; TIA, transient ischaemic attack.